Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Korean Circulation Journal|January 21, 2026
Perspectives on Registry-Based Research in Heart Failure: Current Status and Future DirectionsChristian Basile, Felix Lindberg, Gianluigi Savarese
Diabetologia|December 21, 2023
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonistsGianluigi Savarese, Felix Lindberg, Gerasimos Filippatos, et al.
European Journal of Heart Failure|October 28, 2024
Trends in heart failure mortality in Sweden between 1997 and 2022Felix Lindberg, Lina Benson, Ulf Dahlström, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 19, 2023
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fractionDavide Stolfo, Lars H Lund, Gianfranco Sinagra, et al.
European Journal of Heart Failure|April 28, 2023
Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative projectFelix Lindberg, Lars H Lund, Lina Benson, et al.
European Journal of Heart Failure|August 24, 2022
Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure RegistryFelix Lindberg, Lars H Lund, Lina Benson, et al.
European Journal of Heart Failure|July 30, 2024
Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lina Benson, Felix Lindberg, et al.
ESC Heart Failure|February 16, 2022
Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failureFelix Lindberg, Lars H Lund, Lina Benson, et al.
Lakartidningen|December 9, 2025
[Treatment of heart failure in Sweden: progress but not there yet]Felix Lindberg, Charlotta Ljungman, Camilla Hage, et al.
Plos One|May 24, 2024
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure RegistryFelix Lindberg, Natanael Øigaard, Marco Metra, et al.
Pageof 4